| pubmed-article:17584325 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17584325 | lifeskim:mentions | umls-concept:C0015230 | lld:lifeskim |
| pubmed-article:17584325 | lifeskim:mentions | umls-concept:C0666743 | lld:lifeskim |
| pubmed-article:17584325 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
| pubmed-article:17584325 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:17584325 | pubmed:dateCreated | 2007-6-22 | lld:pubmed |
| pubmed-article:17584325 | pubmed:abstractText | Although antitumor necrosis factor (anti-TNF)-alpha therapy provides beneficial effects on various chronic inflammatory skin diseases including psoriasis, cutaneous side-effects have also been reported. We describe four patients who showed psoriasiform eruption following anti-TNF-alpha therapy (infliximab) for Crohn's disease. In all patients, Crohn's disease had responded well to infliximab. Three patients developed plaque-type psoriasiform eruption on the trunk and four extremities, while one patient showed pustular eruption on the palms and soles accompanied with plaque-type psoriasis. In all these patients, skin lesions subsided with topical application of corticosteroid ointment or psoralen plus ultraviolet A treatment. | lld:pubmed |
| pubmed-article:17584325 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17584325 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17584325 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17584325 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17584325 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17584325 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17584325 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17584325 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17584325 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:17584325 | pubmed:issn | 0385-2407 | lld:pubmed |
| pubmed-article:17584325 | pubmed:author | pubmed-author:KohgoYutakaY | lld:pubmed |
| pubmed-article:17584325 | pubmed:author | pubmed-author:Ishida-Yamamo... | lld:pubmed |
| pubmed-article:17584325 | pubmed:author | pubmed-author:TakahashiHide... | lld:pubmed |
| pubmed-article:17584325 | pubmed:author | pubmed-author:IizukaHajimeH | lld:pubmed |
| pubmed-article:17584325 | pubmed:author | pubmed-author:HashimotoYosh... | lld:pubmed |
| pubmed-article:17584325 | pubmed:author | pubmed-author:AshidaToshifu... | lld:pubmed |
| pubmed-article:17584325 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17584325 | pubmed:volume | 34 | lld:pubmed |
| pubmed-article:17584325 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17584325 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17584325 | pubmed:pagination | 468-72 | lld:pubmed |
| pubmed-article:17584325 | pubmed:meshHeading | pubmed-meshheading:17584325... | lld:pubmed |
| pubmed-article:17584325 | pubmed:meshHeading | pubmed-meshheading:17584325... | lld:pubmed |
| pubmed-article:17584325 | pubmed:meshHeading | pubmed-meshheading:17584325... | lld:pubmed |
| pubmed-article:17584325 | pubmed:meshHeading | pubmed-meshheading:17584325... | lld:pubmed |
| pubmed-article:17584325 | pubmed:meshHeading | pubmed-meshheading:17584325... | lld:pubmed |
| pubmed-article:17584325 | pubmed:meshHeading | pubmed-meshheading:17584325... | lld:pubmed |
| pubmed-article:17584325 | pubmed:meshHeading | pubmed-meshheading:17584325... | lld:pubmed |
| pubmed-article:17584325 | pubmed:meshHeading | pubmed-meshheading:17584325... | lld:pubmed |
| pubmed-article:17584325 | pubmed:meshHeading | pubmed-meshheading:17584325... | lld:pubmed |
| pubmed-article:17584325 | pubmed:meshHeading | pubmed-meshheading:17584325... | lld:pubmed |
| pubmed-article:17584325 | pubmed:meshHeading | pubmed-meshheading:17584325... | lld:pubmed |
| pubmed-article:17584325 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17584325 | pubmed:articleTitle | Psoriasiform and pustular eruption induced by infliximab. | lld:pubmed |
| pubmed-article:17584325 | pubmed:affiliation | Department of Dermatology, Asahikawa Medical College, Asahikawa, Japan. ht@asahikawa-med.ac.jp | lld:pubmed |
| pubmed-article:17584325 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17584325 | pubmed:publicationType | Case Reports | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17584325 | lld:pubmed |
